C15 Ceramide (d18:1/15:0)
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Category | Bile Acid Standards |
Catalog NO. | BPG-3153 |
Product Name | C15 Ceramide (d18:1/15:0) |
CAS | 67492-15-3 |
Molecular Formula | C33H65NO3 |
Molecular Weight | 523.87 |
- Scheme Design
- Custom Synthesis
- cGMP Manufacturing
- Quality Assurance
- Product Information
- Application
- References
- Documents
- Reviews
Description | C15 Ceramide (d18:1/15:0) is a naturally occurring ceramide that has been found in L. nidifica and A. glomerata extracts, human erythrocytes, and the stratum corneum of P. domesticus. Ceramide plays a key role in the anabolic and catabolic pathways of sphingolipids. It acts as an extracellular stimuli for many cellular processes like differentiation, growth suppression, cell senescence and apoptosis. |
Synonyms | N-(pentadecanoyl)-4E-sphingenine; N-pentadecanoyl-D-erythro-sphingosine; Cer(d18:1(4E)/15:0); C15 D-erythro Ceramide (d18:1/15:0) |
IUPAC Name | N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]pentadecanamide |
Canonical SMILES | CCCCCCCCCCCCCCC(=O)NC(CO)C(C=CCCCCCCCCCCCCC)O |
InChI | InChI=1S/C33H65NO3/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-32(36)31(30-35)34-33(37)29-27-25-23-21-19-16-14-12-10-8-6-4-2/h26,28,31-32,35-36H,3-25,27,29-30H2,1-2H3,(H,34,37)/b28-26+/t31-,32+/m0/s1 |
InChIKey | HBULQAPKKLNTLT-STSAHMJASA-N |
Purity | >99% |
Shelf Life | 1 Year |
Storage | Store at -20°C |
Exact Mass | 523.5 |
Hygroscopic | No |
Light Sensitive | No |
Percent Composition | C 75.66%, H 12.51%, N 2.67%, O 9.16% |
C15 Ceramide (d18:1/15:0) is widely regarded for its pivotal role in dermatological applications, particularly in skincare products aimed at enhancing barrier function. The molecule's ability to repair and reinforce the skin's natural barrier is essential for individuals with conditions such as eczema and psoriasis. By integrating C15 Ceramide into moisturizers and topical treatments, manufacturers address common issues like dehydration, irritation, and sensitivity. This biochemical marvel restores the lipid structure in the stratum corneum, leading to improved skin hydration and resilience. Such properties make it a star ingredient in high-performance skincare formulations focused on barrier repair and maintenance. Beyond skincare, C15 Ceramide (d18:1/15:0) holds promise in the field of neurobiology. Ceramides play a crucial role in neuronal signaling and brain health, with particular emphasis on their involvement in cell signaling pathways related to growth, differentiation, and apoptosis. Research into ceramide's impact on neurodegenerative diseases like Alzheimer's and Parkinson's is burgeoning. By modulating ceramide levels in neural tissues, scientists aim to decipher new therapeutic strategies that could slow or even reverse disease progression, offering hope for enhanced cognitive function and neuroprotection. In oncology, C15 Ceramide (d18:1/15:0) is investigated for its potential anti-cancer properties. Ceramide is known to induce apoptosis in cancer cells, making it a focal point for developing novel treatments. Researchers explore how manipulating ceramide metabolism or mimicking its effects can potentially starve tumors of their proliferative capabilities. By understanding and harnessing ceramide's apoptotic pathways, new chemotherapeutic agents aim not only to kill cancer cells more efficiently but to reduce the side effects compared to traditional treatments. The specificity and potency of C15 Ceramide in triggering cancer cell death present a promising avenue for future anti-cancer therapies. Lastly, C15 Ceramide (d18:1/15:0) finds crucial applications in the area of metabolic diseases, including diabetes and obesity. Ceramides are implicated in the regulation of insulin signaling and lipid metabolism. Elevated levels of certain ceramides are associated with insulin resistance and metabolic dysregulation. By targeting ceramide synthesis or its metabolic pathways, researchers hope to develop new interventions that improve insulin sensitivity and metabolic outcomes. Such advancements could lead to innovative treatments that better manage or even prevent metabolic syndrome, reducing the burden of these pervasive health challenges. |
References | 1. Régnier M, Polizzi A, Smati S, Lukowicz C, Fougerat A, Lippi Y, Fouché E, Lasserre F, Naylies C, Bétoulières C, Barquissau V, Mouisel E, Bertrand-Michel J, Batut A, Saati TA, Canlet C, Tremblay-Franco M, Ellero-Simatos S, Langin D, Postic C, Wahli W, Loiseau N, Guillou H, Montagner A. Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity. Sci Rep. 2020 Apr 16;10(1):6489. doi: 10.1038/s41598-020-63579-3. PMID: 32300166; PMCID: PMC7162950. PubMed ID: 32300166. |
Reviews
If you have any suggestions or comments about mPEG-Br, please submit a review immediately.
Why BOC Sciences?
-
Large Stock
More than 2000+ products in inventory
-
Global Delivery
Warehouses in multiple cities to ensure fast delivery
-
mg to kg
Multi specification for academic research and industrial production
-
24/7 Technical Support
Strict process parameter control to ensure product quality
Products
- Lipids
- PEG Derivatives by Structure
-
PEG Derivatives by Functional Group
- Acrylate/Acrylamide/Methacrylate PEG
- Aldehyde (Ald/CHO)PEG
- Alkyne PEG
- Amino PEG, PEG amine(-NH2)
- Azide PEG, Azido PEG(-N3)
- Biotin PEG
- Boc/Fmoc protected amine PEG
- Carboxylic Acid(-COOH) PEG
- Cholesterol PEG
- DBCO PEG
- DNP PEG
- DSPE PEG
- Epoxide glycidyl ether PEG
- FITC PEG
- Folate PEG
- Halide (chloride, bromide) PEG
- Hydrazide PEG
- Hydroxyl(-OH) PEG
- Maleimide(-MAL) PEG
- NHS ester PEG
- Nitrophenyl carbonate (NPC) PEG
- Norbornene PEG
- Olefin/Alkene/Vinyl PEG
- Orthopyridyl disulfide (OPSS) PEG
- Phosphate PEG
- Rhodamine PEG
- SCM PEG
- Silane PEG
- SPDP PEG
- Sulfonate (tosyl, mesyl, tresyl) PEG
- tert-Butyl protected carboxylate PEG
- Thiol(-SH) PEG
- Vinylsulfone PEG
- PEG Copolymers
-
PEG Raw Materials
- Small-molecule Polyethylene Glycol
- Polyethylene Glycol 1000
- Polyethylene Glycol 10000
- Polyethylene Glycol 1500
- Polyethylene Glycol 200
- Polyethylene Glycol 2000
- Polyethylene Glycol 20000
- Polyethylene Glycol 400
- Polyethylene Glycol 4000
- Polyethylene Glycol 600
- Polyethylene Glycol 6000
- Polyethylene Glycol 800
- Polyethylene Glycol 8000
Resources
-
Technical Information
- Aqueous Two-Phase System (ATPS) Technique
- Capillary Electrophoresis (CE) Technique
- Enzyme-linked immunosorbent assay (ELISA) Technique
- High performance liquid chromatography (HPLC) Technique
- How to Perform Polyethylene Glycol (PEG) Modification?
- Hydrophobic Interaction Chromatography (HIC) Technique
- Introduction of Polyethylene Glycol (PEG)
- Ion Exchange Chromatography (IEX) Technique
- PEG for Chemical Synthesis
- PEG for Cosmetic Application
- PEG for Drug Delivery
- PEG for Imaging Diagnosis
- PEG for Pharmaceutical Preparation
- PEG for Tissue Engineering
- PEG Purification Techniques of Plasmid DNA
- PEGylated Protein Purification Techniques
- Polyethylene Glycol (PEG) Modifier Selection Guide
- Radiolabeling Technique
- SDS-PAGE Technique
- Size Exclusion Chromatography (SEC) Technique
- Ultrafiltration Technique
-
Industry News
- Applications of PEG-DSPE: Drug Carriers and Drug Delivery
- Applications of Polyethylene Glycol (PEG) as Medical Devices
- Cholesterol: Definition, Structure, Synthesis, Types and Functions
- Classification of Lipid-Based Vaccine Adjuvants
- FDA approved PEGylated Products
- FDA-Approved Antibody-Drug Conjugates up to 2024
- How are Liposomes Different from Micelles?
- How Lipid Nanoparticles (LNPs) Deliver RNA Drugs?
- Hyaluronic Acid & PEGylated Hyaluronic Acid
- Ionizable Lipids for RNA Delivery
- Lipid Classification and Drug Delivery Systems
- Lipid Formulations: Key Absorption-Enhancing Technologies in New Drug Development
- Lipid-Drug Conjugates (LDCs) for Nanoparticle Drug Delivery
- Liposome in Drug Delivery
- Overview of Liposome Preparation Process
- PEG in Pharmaceutical Preparations (I): Solvents, Lubricants, Adhesives and More
- PEG in Pharmaceutical Preparations (II): Stabilizers, Plasticizers and Modification Materials
- PEG Linkers in Antibody Drug Conjugates and PROTACs
- PEG-DSPE Block Copolymers and Their Derivatives
- PEGylated Drugs: Definition, Structure, Classification and Benefits
- PEGylated RGD Peptides: A Promising Tool for Targeted Drug Delivery
- Pharmacokinetics and Bioanalysis of PEGylated Drugs
- Polyethylene Glycol (PEG) Modified Targeting Nanomaterials
- Preparation Method of PEG Hydrogel
- The PROTAC Technology in Drug Development
- Vaccines: Definition, History, Ingredients, Types and Mechanism of Action
- What are Lipid Excipients and Their Applications?
- What are Lipid Nanoparticles and Their Applications?
- What are Lipid-Drug Conjugates (LDCs)?
- What are Lipids?
- What are Monodispersed and Polydispersed PEGs?
- What are PEG Lipids?
- What are Phospholipids?
- What are Sterols? - Definition, Structure, Function, Examples and Uses
- What is Biotinylation and Biotinylated PEG?
- What is Click Chemistry?
- What is Hydrogel?
- What is Methoxy Polyethylene Glycol (mPEG)?
- What is Nanogels and Its Applications?
- What is the Formulation of Lipid Nanoparticles (LNPs)?
Our Feature
BOC Sciences supplies a unique variety of PEG derivatives and functional PEG polymers. Our products offer the most diverse collection of reactivity, ready-to-use functionality, and molecular weight options that you will not find anywhere else.
PEGylation of Peptides
and Proteins
Reduce the Immunogenicity of Peptide/Protein Drugs
Learn More
APPLICATIONS
PEG linkers For Drug
Improved Circulation Half-Life
Learn More
Have Customer Reviewed On Us?
Chat With Us